Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
about
Improvement of research quality in the fields of orthopaedics and trauma: a global perspectiveSteps in the undertaking of a systematic review in orthopaedic surgeryNonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-AnalysisAdherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.Bone mineral density is not related to heterotopic ossification after total hip arthroplasty.Risk factors for the development of heterotopic ossification in seriously burned adults: A National Institute on Disability, Independent Living and Rehabilitation Research burn model system database analysisHeterotopic ossification following hip arthroplasty: a comparative radiographic study about its development with the use of three different kinds of implants.Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?Blast injuries and heterotopic ossificationIncidence of heterotopic ossification in direct anterior vs posterior approach to total hip arthroplasty: a retrospective radiographic review.Heterotopic Ossification Following Upper Extremity Injury.Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.The efficacy of a multimodal analgesia protocol in preventing heterotopic ossification after acetabular fractures surgery.Heterotopic Ossification and Hypertrophic Scars.Acetabuloplasty with bone grafting in uncemented hip replacement for protrusion.Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis
P2860
Q24289506-C49036AC-EFFA-44F7-97B4-6C148AA59A13Q26866555-E297D343-DDEF-4D31-B379-0C0FC15837F4Q28088671-B7F86018-6EE3-4D0F-AA02-DCB05DCB6E33Q35949108-B991DD48-1E09-4F25-8B88-20D796BE6B07Q35962845-C67AEF7D-6EF7-4110-9993-3970A10983A5Q36210631-D8B7A077-FA9D-4F7D-8B84-CC6E87AED7B8Q36278581-4DE9D445-D662-45CB-B713-36DA37FD36A7Q36721990-B35774E8-3ED3-401D-9870-2B42ECA2D3E6Q36765543-A80B2092-4461-4C82-93CF-EA9C373E5A36Q38649623-271D62E8-D5DE-425B-B28E-500DEDE811E2Q39211457-D8747A9A-CEA8-4A0B-A42B-E0D209F0A7A0Q40180139-66AAC344-5D1B-4CD4-B311-CF826E266C8DQ41002039-2CE8D67E-E5B5-49EE-8FBA-F20BDE4E136EQ48149635-724FE734-B7D3-4E68-9E28-DA05C916F331Q50189033-B4125945-A6E8-4D2A-A269-2F9AC29C7691Q53223022-03A11A01-5F5A-408F-8C5C-0AF0EABC9E4FQ58802042-3BF6FE6A-C0D9-4D3A-AE3D-C3F27B51F5DA
P2860
Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@ast
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@en
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@nl
type
label
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@ast
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@en
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@nl
prefLabel
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@ast
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@en
Selective COX-2 inhibitor vers ...... analysis of randomised trials.
@nl
P2093
P2860
P1476
Selective COX-2 inhibitor vers ...... -analysis of randomised trials
@en
P2093
Qiang Zheng
Shengjun Qian
Zhijun Pan
P2860
P2888
P356
10.1007/S00264-009-0886-Y
P50
P577
2009-10-15T00:00:00Z
P5875
P6179
1053010661